Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in ALNYLAM PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 389,435 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $154.9M as of 2025-Q4. The position was increased (++154.5% shares). ALNY represents 0.1% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$154.9M
Current Shares
389,435
Total Value Change
+$124.2M
Total Shares Change
+263,423
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 389,435 |
+154.5% |
| $154.9M |
| 0.1% |
| $397.25 |
49 |
| 2025-Q3 | Increased | 153,039 | +19.0% | $69.8M | 0.0% | $447.49 | 35 |
| 2025-Q2 | Increased | 128,634 | +202.1% | $41.9M | 0.0% | $322.83 | 47 |
| 2025-Q1 | Increased | 42,575 | +2.0% | $11.5M | 0.0% | $268.46 | 28 |
| 2024-Q4 | Decreased | 41,718 | -63.7% | $9.8M | 0.0% | $236.01 | 0 |
| 2024-Q3 | Decreased | 114,784 | -8.9% | $31.6M | 0.0% | $274.91 | 0 |
| 2024-Q2 | Increased | 126,012 | +24.2% | $30.6M | 0.0% | $243.00 | 35 |